Literature DB >> 18723077

Elevated myeloperoxidase activity in white matter in multiple sclerosis.

Elizabeth Gray1, Taya Louise Thomas, Samar Betmouni, Neil Scolding, Seth Love.   

Abstract

Recent studies have revealed extensive axonal damage in patients with progressive multiple sclerosis (MS). Axonal damage can be caused by a plethora of factors including the release of proteolytic enzymes and cytotoxic oxidants by activated immune cells and glia within the lesion. Macrophages and microglia are known to express myeloperoxidase (MPO) and generate reactive oxygen species during myelin phagocytosis in the white matter. In the present study we have measured MPO levels in post-mortem homogenates of demyelinated and non-demyelinated regions of white matter from nine patients with MS and seven controls, and assessed MPO immunoreactivity within MS brain. In homogenates of MS white matter, demyelination was associated with significantly elevated MPO activity when compared to controls. Immunohistochemistry showed MPO to be expressed mainly by macrophages within and adjacent to plaques. Demyelination in MS is associated with increased activity of MPO, suggesting that this production of reactive oxygen species may contribute to axonal injury within plaques.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18723077     DOI: 10.1016/j.neulet.2008.08.035

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  39 in total

1.  Demyelinating diseases: myeloperoxidase as an imaging biomarker and therapeutic target.

Authors:  Reza Forghani; Gregory R Wojtkiewicz; Yinian Zhang; Daniel Seeburg; Benjamin R M Bautz; Benjamin Pulli; Andrew R Milewski; Wendy L Atkinson; Yoshiko Iwamoto; Elizabeth R Zhang; Martin Etzrodt; Elisenda Rodriguez; Clinton S Robbins; Filip K Swirski; Ralph Weissleder; John W Chen
Journal:  Radiology       Date:  2012-03-21       Impact factor: 11.105

2.  An activatable PET imaging radioprobe is a dynamic reporter of myeloperoxidase activity in vivo.

Authors:  Cuihua Wang; Edmund Keliher; Matthias W G Zeller; Gregory R Wojtkiewicz; Aaron D Aguirre; Leonard Buckbinder; Hye-Yeong Kim; Jianqing Chen; Kevin Maresca; Maaz S Ahmed; Negin Jalali Motlagh; Matthias Nahrendorf; John W Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2019-05-23       Impact factor: 11.205

3.  Hypochlorite modification of sphingomyelin generates chlorinated lipid species that induce apoptosis and proteome alterations in dopaminergic PC12 neurons in vitro.

Authors:  Christoph Nusshold; Manfred Kollroser; Harald Köfeler; Gerald Rechberger; Helga Reicher; Andreas Ullen; Eva Bernhart; Sabine Waltl; Ingrid Kratzer; Albin Hermetter; Hubert Hackl; Zlatko Trajanoski; Andelko Hrzenjak; Ernst Malle; Wolfgang Sattler
Journal:  Free Radic Biol Med       Date:  2010-03-11       Impact factor: 7.376

4.  Effects of Myeloperoxidase on Methicillin-Resistant Staphylococcus aureus-Colonized Burn Wounds in Rats.

Authors:  Ren Guo; Shuaihua Li; Hansong Xia; Zhicai Feng; Qiyu Tang; Cheng Peng
Journal:  Adv Wound Care (New Rochelle)       Date:  2019-07-02       Impact factor: 4.730

Review 5.  Myeloperoxidase: A new player in autoimmunity.

Authors:  Anna Strzepa; Kirkwood A Pritchard; Bonnie N Dittel
Journal:  Cell Immunol       Date:  2017-05-10       Impact factor: 4.868

6.  Multiple sclerosis: myeloperoxidase immunoradiology improves detection of acute and chronic disease in experimental model.

Authors:  Benjamin Pulli; Lionel Bure; Gregory R Wojtkiewicz; Yoshiko Iwamoto; Muhammad Ali; Dan Li; Stefan Schob; Kevin Li-Chun Hsieh; Andreas H Jacobs; John W Chen
Journal:  Radiology       Date:  2014-12-10       Impact factor: 11.105

7.  Manual Segmentation of MS Cortical Lesions Using MRI: A Comparison of 3 MRI Reading Protocols.

Authors:  J Maranzano; D A Rudko; D L Arnold; S Narayanan
Journal:  AJNR Am J Neuroradiol       Date:  2016-05-19       Impact factor: 3.825

Review 8.  Oxidative/Nitroxidative Stress and Multiple Sclerosis.

Authors:  Tobore Onojighofia Tobore
Journal:  J Mol Neurosci       Date:  2020-08-07       Impact factor: 3.444

9.  Inhibition of myeloperoxidase at the peak of experimental autoimmune encephalomyelitis restores blood-brain barrier integrity and ameliorates disease severity.

Authors:  Hao Zhang; Avijit Ray; Nichole M Miller; Danielle Hartwig; Kirkwood A Pritchard; Bonnie N Dittel
Journal:  J Neurochem       Date:  2015-11-30       Impact factor: 5.372

Review 10.  Is multiple sclerosis a mitochondrial disease?

Authors:  Peizhong Mao; P Hemachandra Reddy
Journal:  Biochim Biophys Acta       Date:  2009-07-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.